Global Immune system drugs Detailed Analysis Report 2017-2022

August 2017 | 120 pages | ID: GC6B648074CEN
Detailed-Analysis Research (DAR)

Abstracts

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Immune system drugs industry.
This report splits Immune system drugs market by Immunosuppressive drugs, by Immunoregulants, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:
Major Companies

• ABBVIE
• ACCORD HLTHCARE
• AKORN INC
• ALLERGAN
• AMNEAL PHARMS LLC
• ANTARES PHARMA INC
• APOTEX
• ASTELLAS
• BAXTER HLTHCARE
• BAYER HEALTHCARE PHARMS
• DAVA PHARMS INC
• DR REDDYS LABS LTD
• FRESENIUS KABI USA
• GLENMARK GENERICS
• HOSPIRA
• IVAX SUB TEVA PHARMS
• MAYNE PHARMA
• MYLAN
• NOVARTIS
• ROCHE PALO
• SANDOZ
• SANOFI AVENTIS US
• STRIDES PHARMA
• TEVA PHARMS
• VELOXIS PHARMS INC
• VIDARA THERAPEUTICS RESEARCH LTD
• VINTAGE PHARMS LLC
• WATSON LABS
• WEST-WARD PHARMS INT
• ZYDUS PHARMS USA

Main Regions

• North America
• United States
• Canada
• Latin America
• Mexico
• Brazil
• Argentina
• Others
• Europe
• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia
• Netherland
• Others
• Asia & Pacific
• China
• Japan
• India
• Korea
• Australia
• Southeast Asia
• Indonesia
• Thailand
• Philippines
• Vietnam
• Singapore
• Malaysia
• Others
• Africa & Middle East
• South Africa
• Egypt
• Turkey
• Saudi Arabia
• Iran
• Others

Main Product Type
Immune system drugs Market, by Immunosuppressive drugs

• Azathioprine
• Tripterygium Glycosides
• Cyclosporine
• Sandimmune
• Ciclosporin
• Cyclosporine
• Neoral
• Tacrolimus
• Rapamycin
• Mycophenolate
• Everolimus
• Diacerein
• Mizoribine
• Gusperimus
• Etanercept
• Muromonab-CD3
• Cyclophosphamide
• Fingolimod
• Leflunomide
• Imiquimod
• Chloroquinum
• Methotrexate

Immune system drugs Market, by Immunoregulants

• Inosine pranobex
• Melotonin
• Killer helper factor,KHF
• Thymopentin
• Interleukin
• γ-globulin
• Interferon
• Ubenimex
• Pidotimod
• Thymopentin

Main Applications

• Internal Medicine
• Department of surgery
• Infections Department
• Hospital

Contents

Global Immune system drugs Detailed Analysis Report 2017-2022

CHAPTER ONE IMMUNE SYSTEM DRUGS MARKET OVERVIEW

1.1 Global Immune system drugs Market Sales Volume Revenue and Price 2012-2022
1.2 Immune system drugs, by Immunosuppressive drugs 2012-2022
  1.2.1 Global Immune system drugs Sales Market Share by Immunosuppressive drugs 2012-2022
  1.2.2 Global Immune system drugs Revenue Market Share by Immunosuppressive drugs 2012-2022
  1.2.3 Global Immune system drugs Price by Immunosuppressive drugs 2012-2022
  1.2.4 Azathioprine
  1.2.5 Tripterygium Glycosides
  1.2.6 Cyclosporine
  1.2.7 Sandimmune
  1.2.8 Ciclosporin
Cyclosporine
Neoral
Tacrolimus
Rapamycin
Mycophenolate
Everolimus
Diacerein
Mizoribine
Gusperimus
Etanercept
Muromonab-CD3
Cyclophosphamide
Fingolimod
Leflunomide
Imiquimod
Chloroquinum
Methotrexate
1.3 Immune system drugs, by Immunoregulants 2012-2022
  1.3.1 Global Immune system drugs Sales Market Share by Immunoregulants 2012-2022
  1.3.2 Global Immune system drugs Revenue Market Share by Immunoregulants 2012-2022
  1.3.3 Global Immune system drugs Price by Immunoregulants 2012-2022
  1.3.4 Inosine pranobex
  1.3.5 Melotonin
  1.3.6 Killer helper factor,KHF
  1.3.7 Thymopentin
  1.3.8 Interleukin
γ-globulin
Interferon
Ubenimex
Pidotimod
Thymopentin

CHAPTER TWO IMMUNE SYSTEM DRUGS BY REGIONS 2012-2017

2.1 Global Immune system drugs Sales Market Share by Regions 2012-2017
2.2 Global Immune system drugs Revenue Market Share by Regions 2012-2017
2.3 Global Immune system drugs Price by Regions 2012-2017
2.4 North America
  2.4.1 United States
  2.4.2 Canada
2.5 Latin America
  2.5.1 Mexico
  2.5.2 Brazil
  2.5.3 Argentina
  2.5.4 Others in Latin America
2.6 Europe
  2.6.1 Germany
  2.6.2 United Kingdom
  2.6.3 France
  2.6.4 Italy
  2.6.5 Spain
  2.6.6 Russia
  2.6.7 Netherland
  2.6.8 Others in Europe
2.7 Asia & Pacific
  2.7.1 China
  2.7.2 Japan
  2.7.3 India
  2.7.4 Korea
  2.7.5 Australia
  2.7.6 Southeast Asia
    2.7.6.1 Indonesia
    2.7.6.2 Thailand
    2.7.6.3 Philippines
    2.7.6.4 Vietnam
    2.7.6.5 Singapore
    2.7.6.6 Malaysia
    2.7.6.7 Others in Southeast Asia
2.8 Africa & Middle East
  2.8.1 South Africa
  2.8.2 Egypt
  2.8.3 Turkey
  2.8.4 Saudi Arabia
  2.8.5 Iran
  2.8.6 Others in Africa & Middle East

CHAPTER THREE IMMUNE SYSTEM DRUGS BY PLAYERS 2012-2017

3.1 Global Immune system drugs Sales Volume Market Share by Players 2012-2017
3.2 Global Immune system drugs Revenue Share by Players 2012-2017
3.3 Global Top Players Immune system drugs Key Product Model and Market Performance
3.4 Global Top Players Immune system drugs Key Target Consumers and Market Performance

CHAPTER FOUR IMMUNE SYSTEM DRUGS BY CONSUMER 2012-2017

4.1 Global Immune system drugs Sales Market Share by Consumer 2012-2017
4.2 Internal Medicine
4.3 Department of surgery
4.4 Infections Department
4.5 Hospital
4.6 Consuming Habit and Preference

CHAPTER FIVE GLOBAL TOP PLAYERS PROFILE

5.1 ABBVIE
  5.1.1 ABBVIE Company Details and Competitors
  5.1.2 ABBVIE Key Immune system drugs Models and Performance
  5.1.3 ABBVIE Immune system drugs Business SWOT Analysis and Forecast
  5.1.4 ABBVIE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.2 ACCORD HLTHCARE
  5.2.1 ACCORD HLTHCARE Company Details and Competitors
  5.2.2 ACCORD HLTHCARE Key Immune system drugs Models and Performance
  5.2.3 ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
  5.2.4 ACCORD HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.3 AKORN INC
  5.3.1 AKORN INC Company Details and Competitors
  5.3.2 AKORN INC Key Immune system drugs Models and Performance
  5.3.3 AKORN INC Immune system drugs Business SWOT Analysis and Forecast
  5.3.4 AKORN INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.4 ALLERGAN
  5.4.1 ALLERGAN Company Details and Competitors
  5.4.2 ALLERGAN Key Immune system drugs Models and Performance
  5.4.3 ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
  5.4.4 ALLERGAN Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.5 AMNEAL PHARMS LLC
  5.5.1 AMNEAL PHARMS LLC Company Details and Competitors
  5.5.2 AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
  5.5.3 AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
  5.5.4 AMNEAL PHARMS LLC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.6 ANTARES PHARMA INC
  5.6.1 ANTARES PHARMA INC Company Details and Competitors
  5.6.2 ANTARES PHARMA INC Key Immune system drugs Models and Performance
  5.6.3 ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
  5.6.4 ANTARES PHARMA INC Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.7 APOTEX
  5.7.1 APOTEX Company Details and Competitors
  5.7.2 APOTEX Key Immune system drugs Models and Performance
  5.7.3 APOTEX Immune system drugs Business SWOT Analysis and Forecast
  5.7.4 APOTEX Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.8 ASTELLAS
  5.8.1 ASTELLAS Company Details and Competitors
  5.8.2 ASTELLAS Key Immune system drugs Models and Performance
  5.8.3 ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
  5.8.4 ASTELLAS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.9 BAXTER HLTHCARE
  5.9.1 BAXTER HLTHCARE Company Details and Competitors
  5.9.2 BAXTER HLTHCARE Key Immune system drugs Models and Performance
  5.9.3 BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
  5.9.4 BAXTER HLTHCARE Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.10 BAYER HEALTHCARE PHARMS
  5.10.1 BAYER HEALTHCARE PHARMS Company Details and Competitors
  5.10.2 BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
  5.10.3 BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
  5.10.4 BAYER HEALTHCARE PHARMS Immune system drugs Sales Volume Revenue Price Cost and Gross Margin
5.11 DAVA PHARMS INC
5.12 DR REDDYS LABS LTD
5.13 FRESENIUS KABI USA
5.14 GLENMARK GENERICS
5.15 HOSPIRA
5.16 IVAX SUB TEVA PHARMS
5.17 MAYNE PHARMA
5.18 MYLAN
5.19 NOVARTIS
5.20 ROCHE PALO
5.21 SANDOZ
5.22 SANOFI AVENTIS US
5.23 STRIDES PHARMA
5.24 TEVA PHARMS
5.25 VELOXIS PHARMS INC
5.26 VIDARA THERAPEUTICS RESEARCH LTD
5.27 VINTAGE PHARMS LLC
5.28 WATSON LABS
5.29 WEST-WARD PHARMS INT
5.30 ZYDUS PHARMS USA

CHAPTER SIX INDUSTRY CHAIN AND SUPPLY CHAIN

6.1 Immune system drugs Industry Chain Structure
  6.1.1 R&D
  6.1.2 Raw Materials (Components)
  6.1.3 Manufacturing Plants
  6.1.4 Regional Trading (Import Export and Local Sales)
  6.1.5 Online Sales Channel
  6.1.6 Offline Channel
  6.1.7 End Users
6.2 Immune system drugs Manufacturing
  6.2.1 Key Components
  6.2.2 Assembly Manufacturing
6.3 Consumer Preference
6.4 Behavioral Habits
6.5 Marketing Environment

CHAPTER SEVEN GLOBAL IMMUNE SYSTEM DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

7.1 Global Immune system drugs Sales (Million Units), Revenue (Million USD) Forecast (2017-2022)
7.2 Global Immune system drugs Sales (Million Units) Forecast by Regions (2017-2022)
7.3 Global Immune system drugs Sales (Million Units) Forecast by Application (2017-2022)
7.4 Global Immune system drugs Sales (Million Units) Forecast by Immunosuppressive drugs (2017-2022)
7.5 Global Immune system drugs Sales (Million Units) Forecast by Immunoregulants (2017-2022)

CHAPTER EIGHT DEVELOPMENT TREND AND RESEARCH CONCLUSION

8.1 Development Trend
8.2 Research Conclusion

CHAPTER NINE METHODOLOGY AND DATA SOURCE

9.1 Methodology/Research Approach
  9.1.1 Research Programs/Design
  9.1.2 Market Size Estimation
  9.1.3 Market Breakdown and Data Triangulation
9.2 Data Source
  9.2.1 Secondary Sources
  9.2.2 Primary Sources
9.3 Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Table Global Immune system drugs Sales Volume (), Revenue (Million USD) and Price () (2012-2017)
Figure Global Immune system drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Global Immune system drugs Sales Volume () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Immunosuppressive drugs (2012-2017)
Table Global Immune system drugs Sales Market Share by Immunosuppressive drugs (2012-2017)
Figure Global Immune system drugs Sales Market Share by Immunosuppressive drugs in 2016
Table Global Immune system drugs Revenue (Million USD) by Immunosuppressive drugs (2012-2017)
Table Global Immune system drugs Revenue Market Share by Immunosuppressive drugs (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Immunosuppressive drugs in 2016
Table Global Immune system drugs Price () by Immunosuppressive drugs (2012-2017)
Table Top Players of Azathioprine Immune system drugs Products List
Figure Global Azathioprine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Tripterygium Glycosides Immune system drugs Products List
Figure Global Tripterygium Glycosides Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Cyclosporine Immune system drugs Products List
Figure Global Cyclosporine Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Sandimmune Immune system drugs Products List
Figure Global Sandimmune Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Ciclosporin Immune system drugs Products List
Figure Global Ciclosporin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Immunoregulants (2012-2017)
Table Global Immune system drugs Sales Market Share by Immunoregulants (2012-2017)
Figure Global Immune system drugs Sales Market Share by Immunoregulants in 2016
Table Global Immune system drugs Revenue (Million USD) by Immunoregulants (2012-2017)
Table Global Immune system drugs Revenue Market Share by Immunoregulants (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Immunoregulants in 2016
Table Global Immune system drugs Price () by Immunoregulants (2012-2017)
Table Top Players of Inosine pranobex Immune system drugs Products List
Figure Global Inosine pranobex Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Melotonin Immune system drugs Products List
Figure Global Melotonin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Killer helper factor,KHF Immune system drugs Products List
Figure Global Killer helper factor,KHF Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Thymopentin Immune system drugs Products List
Figure Global Thymopentin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Top Players of Interleukin Immune system drugs Products List
Figure Global Interleukin Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales () by Regions (2012-2017)
Table Global Immune system drugs Sales Share by Regions (2012-2017)
Figure Global Immune system drugs Sales Market Share by Regions in 2016
Figure Global Immune system drugs Sales Market Share by Regions in 2017
Table Global Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Global Immune system drugs Revenue Market Share by Regions (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Regions in 2016
Figure Global Immune system drugs Revenue Market Share by Regions in 2017
Table Global Immune system drugs Price () by Regions (2012-2017)
Table North America Immune system drugs Sales () by Regions (2012-2017)
Table North America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table North America Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure North America Immune system drugs Sales () and Growth Rate (2012-2017)
Table Latin America Immune system drugs Sales () by Regions (2012-2017)
Table Latin America Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Latin America Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure Latin America Immune system drugs Sales () and Growth Rate (2012-2017)
Table Europe Immune system drugs Sales () by Regions (2012-2017)
Table Europe Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Europe Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure Europe Immune system drugs Sales () and Growth Rate (2012-2017)
Table Asia & Pacific Immune system drugs Sales () by Regions (2012-2017)
Table Asia & Pacific Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Asia & Pacific Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure Asia & Pacific Immune system drugs Sales () and Growth Rate (2012-2017)
Table Southeast Asia Immune system drugs Sales () by Regions (2012-2017)
Table Southeast Asia Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Southeast Asia Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure Southeast Asia Immune system drugs Sales () and Growth Rate (2012-2017)
Table Africa & Middle East Immune system drugs Sales () by Regions (2012-2017)
Table Africa & Middle East Immune system drugs Revenue (Million USD) by Regions (2012-2017)
Table Africa & Middle East Immune system drugs Sales Volume () by Key Players (2012-2017)
Figure Africa & Middle East Immune system drugs Sales () and Growth Rate (2012-2017)
Table Global Immune system drugs Sales Volume () by Key Players (2012-2017)
Table Global Immune system drugs Sales Volume Market Share by Key Players (2012-2017)
Figure Global Immune system drugs Sales Volume Market Share by Key Players 2016
Figure Global Immune system drugs Sales Volume Market Share by Key Players 2017
Table Global Immune system drugs Revenue (Million USD) by Key Players (2012-2017)
Table Global Immune system drugs Revenue Market Share by Key Players (2012-2017)
Figure Global Immune system drugs Revenue Market Share by Key Players 2016
Figure Global Immune system drugs Revenue Market Share by Key Players 2017
Table Global Top Players Key Product Model and Market Performance
Table Global Top Players Key Target Consumers and Market Performance
Table Global Immune system drugs Sales () by Consumer (2012-2017)
Figure Global Immune system drugs Sales Market Share by Consumer (2012-2017)
Figure Global Immune system drugs Sales Market Share by Consumer in 2016
Figure Global Internal Medicine Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Department of surgery Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Infections Department Immune system drugs Sales () and Growth Rate (2012-2017)
Figure Global Hospital Immune system drugs Sales () and Growth Rate (2012-2017)
Table ABBVIE Company Details and Competitors
Table ABBVIE Key Immune system drugs Models and Performance
Table ABBVIE Immune system drugs Business SWOT Analysis and Forecast
Table ABBVIE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure ABBVIE Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure ABBVIE Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure ABBVIE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure ABBVIE Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table ACCORD HLTHCARE Company Details and Competitors
Table ACCORD HLTHCARE Key Immune system drugs Models and Performance
Table ACCORD HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
Table ACCORD HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure ACCORD HLTHCARE Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure ACCORD HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure ACCORD HLTHCARE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure ACCORD HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table AKORN INC Company Details and Competitors
Table AKORN INC Key Immune system drugs Models and Performance
Table AKORN INC Immune system drugs Business SWOT Analysis and Forecast
Table AKORN INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure AKORN INC Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure AKORN INC Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure AKORN INC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure AKORN INC Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table ALLERGAN Company Details and Competitors
Table ALLERGAN Key Immune system drugs Models and Performance
Table ALLERGAN Immune system drugs Business SWOT Analysis and Forecast
Table ALLERGAN Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure ALLERGAN Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure ALLERGAN Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure ALLERGAN Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure ALLERGAN Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table AMNEAL PHARMS LLC Company Details and Competitors
Table AMNEAL PHARMS LLC Key Immune system drugs Models and Performance
Table AMNEAL PHARMS LLC Immune system drugs Business SWOT Analysis and Forecast
Table AMNEAL PHARMS LLC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure AMNEAL PHARMS LLC Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure AMNEAL PHARMS LLC Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure AMNEAL PHARMS LLC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure AMNEAL PHARMS LLC Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table ANTARES PHARMA INC Company Details and Competitors
Table ANTARES PHARMA INC Key Immune system drugs Models and Performance
Table ANTARES PHARMA INC Immune system drugs Business SWOT Analysis and Forecast
Table ANTARES PHARMA INC Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure ANTARES PHARMA INC Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure ANTARES PHARMA INC Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure ANTARES PHARMA INC Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure ANTARES PHARMA INC Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table APOTEX Company Details and Competitors
Table APOTEX Key Immune system drugs Models and Performance
Table APOTEX Immune system drugs Business SWOT Analysis and Forecast
Table APOTEX Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure APOTEX Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure APOTEX Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure APOTEX Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure APOTEX Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table ASTELLAS Company Details and Competitors
Table ASTELLAS Key Immune system drugs Models and Performance
Table ASTELLAS Immune system drugs Business SWOT Analysis and Forecast
Table ASTELLAS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure ASTELLAS Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure ASTELLAS Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure ASTELLAS Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure ASTELLAS Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table BAXTER HLTHCARE Company Details and Competitors
Table BAXTER HLTHCARE Key Immune system drugs Models and Performance
Table BAXTER HLTHCARE Immune system drugs Business SWOT Analysis and Forecast
Table BAXTER HLTHCARE Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure BAXTER HLTHCARE Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure BAXTER HLTHCARE Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure BAXTER HLTHCARE Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure BAXTER HLTHCARE Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table BAYER HEALTHCARE PHARMS Company Details and Competitors
Table BAYER HEALTHCARE PHARMS Key Immune system drugs Models and Performance
Table BAYER HEALTHCARE PHARMS Immune system drugs Business SWOT Analysis and Forecast
Table BAYER HEALTHCARE PHARMS Immune system drugs Output (), Revenue (Million USD), Price () and Gross Margin (%) (2012-2022)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales (Million Unit) and Growth Rate (%) (2012-2022)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Market Share (%) in Global (2012-2022)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Sales Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure BAYER HEALTHCARE PHARMS Immune system drugs Revenue Market Share (%) in Global (2012-2022)
Table DAVA PHARMS INC Company Details and Competitors
Table DR REDDYS LABS LTD Company Details and Competitors
Table FRESENIUS KABI USA Company Details and Competitors
Table GLENMARK GENERICS Company Details and Competitors
Table HOSPIRA Company Details and Competitors
Table IVAX SUB TEVA PHARMS Company Details and Competitors
Table MAYNE PHARMA Company Details and Competitors
Table MYLAN Company Details and Competitors
Table NOVARTIS Company Details and Competitors
Table ROCHE PALO Company Details and Competitors
Table SANDOZ Company Details and Competitors
Table SANOFI AVENTIS US Company Details and Competitors
Table STRIDES PHARMA Company Details and Competitors
Table TEVA PHARMS Company Details and Competitors
Table VELOXIS PHARMS INC Company Details and Competitors
Table VIDARA THERAPEUTICS RESEARCH LTD Company Details and Competitors
Table VINTAGE PHARMS LLC Company Details and Competitors
Table WATSON LABS Company Details and Competitors
Table WEST-WARD PHARMS INT Company Details and Competitors
Table ZYDUS PHARMS USA Company Details and Competitors
Figure Global Immune system drugs Sales () and Growth Rate (%) Forecast (2017-2022)
Figure Global Immune system drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Immune system drugs Price () Trend Forecast (2017-2022)
Table Global Immune system drugs Sales () Forecast by Regions (2017-2022)
Table Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Immune system drugs Sales Volume Share Forecast by Regions (2017-2022)
Figure Global Immune system drugs Sales Volume Share Forecast by Regions in 2022
Table Global Immune system drugs Sales () Forecast by Application (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Application (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Application in 2022
Table Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure Global Immune system drugs Sales () Forecast by Immunosuppressive drugs (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunosuppressive drugs in 2022
Table Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure Global Immune system drugs Sales () Forecast by Immunoregulants (2017-2022)
Figure Global Immune system drugs Sales Volume Market Share Forecast by Immunoregulants in 2022